Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001437749-26-011116
- form_type
- 8-K
- ticker
- AYTU
- cik
- 0001385818
- company_name
- AYTU BIOPHARMA, INC
- filed_at
- 2026-04-02T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:32.219510+00:00
- generated_at
- 2026-05-15T07:49:26.550762+00:00
- sec_items
- ["1.01", "2.02", "3.02", "3.03", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.6
- calibrated_materiality_score
- 0.6
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001437749-26-011116
- json_url
- https://secwatch.observer/filing/0001437749-26-011116.json
- markdown_url
- https://secwatch.observer/filing/0001437749-26-011116.md
- text_url
- https://secwatch.observer/filing/0001437749-26-011116.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1385818/000143774926011116/0001437749-26-011116-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1385818/000143774926011116/aytu20260327_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
XWIN
XMax raises $3.6M via private placement of 486,500 shares at $7.347/share
XMax Inc.
June 2, 2026, 4:30 PM ET
other_material
Items 1.01, 3.02, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.02, 9.01
same event type: other_material
similar materiality
This filing
the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant ("Amended 2023 Prefunded Warrant"), (ii) an Amended and Restated June 2023 Tranche A Warrant ("Amended 2023 Tranche A Warrant") and (iii) an Amended and Restated June 2025 Prefunded Warrant ("Amended 2025 Prefunded Warrant"), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers
Comparable filing
On May 28, 2026, XMax Inc. (the “ Company ”) entered into Securities Purchase Agreements (the “ Agreements ”) with certain non-U.S. investors identified on the signature pages thereto (the “ Purchasers ”), pursuant to which the Company agreed to sell to the Purchasers in a private placement for a total of 486,500 shares (the “ Shares ”) of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), at a purchase price of $7.347 per share for an aggregate offering price of $3,574,315.50 (the “ Private Placement ”).
Filing page
SEC filing
JAGX
Jaguar Health issues 64,668 common shares for Series Q Preferred; annual meeting adjourned to June 8
Jaguar Health, Inc.
June 2, 2026, 4:10 PM ET
other_material
Items 1.01, 3.02, 8.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.02, 9.01
same event type: other_material
similar materiality
This filing
the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant ("Amended 2023 Prefunded Warrant"), (ii) an Amended and Restated June 2023 Tranche A Warrant ("Amended 2023 Tranche A Warrant") and (iii) an Amended and Restated June 2025 Prefunded Warrant ("Amended 2025 Prefunded Warrant"), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers
Comparable filing
On May 26, 2026, the Company entered into a privately negotiated exchange agreement with Streeterville (the “First Exchange Agreement”), pursuant to which the Company issued 31,958 shares (the “First Exchange Shares”) of the Company’s common stock, par value $0.0001 (the “Common Stock”) to Streeterville in exchange for an aggregate of 3.72 outstanding shares of Series Q Preferred Stock held by Streeterville (the “First Exchanged Preferred Shares”).
Filing page
SEC filing
GNK
Genco Shipping amends shareholder rights plan, eliminates 'Acting in Concert' definition
GENCO SHIPPING & TRADING LTD
June 2, 2026, 6:01 AM ET
other_material
Items 1.01, 3.03, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.03, 9.01
same event type: other_material
similar materiality
This filing
the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant ("Amended 2023 Prefunded Warrant"), (ii) an Amended and Restated June 2023 Tranche A Warrant ("Amended 2023 Tranche A Warrant") and (iii) an Amended and Restated June 2025 Prefunded Warrant ("Amended 2025 Prefunded Warrant"), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers
Comparable filing
On June 2, 2026, Genco Shipping & Trading Limited (the “ Company ”) entered into the Third Amendment to Shareholders Rights Agreement (the “ Third Amendment ”) to amend the Shareholder Rights Agreement, dated as of October 1, 2025 between the Company and Computershare Inc., as amended to date (the “ Rights Agreement ”).
Filing page
SEC filing
TPST
Tempest Therapeutics enters warrant exercise inducement for ~$2M; issues new warrants to purchase 2.34M shares at $1.73
Tempest Therapeutics, Inc.
June 1, 2026, 7:13 PM ET
other_material
Items 1.01, 3.02, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.02, 9.01
same event type: other_material
similar materiality
This filing
the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant ("Amended 2023 Prefunded Warrant"), (ii) an Amended and Restated June 2023 Tranche A Warrant ("Amended 2023 Tranche A Warrant") and (iii) an Amended and Restated June 2025 Prefunded Warrant ("Amended 2025 Prefunded Warrant"), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers
Comparable filing
On May 28, 2026, Tempest Therapeutics, Inc., a Delaware corporation (the “ Company ”), entered into a warrant exercise and inducement offer letter agreement (the “ Inducement Letter ”) with a holder of certain existing warrants to purchase shares of the Company’s common stock
Filing page
SEC filing
CITR
CitroTech exchanges all Series A Preferred for Series C Convertible; BoltRock gets board rights
CitroTech Inc.
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 3.02, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.02, 9.01
same event type: other_material
similar materiality
This filing
the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant ("Amended 2023 Prefunded Warrant"), (ii) an Amended and Restated June 2023 Tranche A Warrant ("Amended 2023 Tranche A Warrant") and (iii) an Amended and Restated June 2025 Prefunded Warrant ("Amended 2025 Prefunded Warrant"), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers
Comparable filing
On May 28, 2026, CitroTech Inc., a Wyoming corporation (the “Company”), entered into Stock Exchange and Stockholders Agreements (the “Exchange Agreements”) with the holders (the “Holders”) of the Company’s outstanding Series A Preferred Stock
Filing page
SEC filing
AAT
AAT board raises Rady Trust ownership cap to 21.9%, lowers general limit to 6.775%
American Assets Trust, Inc.
May 11, 2026, 7:59 PM ET
other_material
Items 1.01, 3.03, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.03, 9.01
same event type: other_material
similar materiality
This filing
the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant ("Amended 2023 Prefunded Warrant"), (ii) an Amended and Restated June 2023 Tranche A Warrant ("Amended 2023 Tranche A Warrant") and (iii) an Amended and Restated June 2025 Prefunded Warrant ("Amended 2025 Prefunded Warrant"), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers
Comparable filing
On May 11, 2026, American Assets Trust, Inc. (the "Company") entered into a Voting Support Agreement (the "Voting Agreement") with the Ernest Rady Trust U/D/T March 10, 1983 (the "Rady Trust"), the Evelyn Shirley Rady Trust U/D/T March 10, 1983, and American Assets, Inc. (collectively, the "Stockholder").
Filing page
SEC filing
SAGU
Shreya Acquisition Group closes $110M IPO, 11M units at $10 each on NYSE
Shreya Acquisition Group
May 11, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.02, 9.01
same event type: other_material
similar materiality
This filing
the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant ("Amended 2023 Prefunded Warrant"), (ii) an Amended and Restated June 2023 Tranche A Warrant ("Amended 2023 Tranche A Warrant") and (iii) an Amended and Restated June 2025 Prefunded Warrant ("Amended 2025 Prefunded Warrant"), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers
Comparable filing
Private Units Subscription Agreement, dated May 6, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 and incorporated herein by reference
Filing page
SEC filing
PBT
Court approves trust indenture amendments eliminating 75% supermajority requirement
PERMIAN BASIN ROYALTY TRUST
May 8, 2026, 7:59 PM ET
other_material
Items 1.01, 3.03, 5.03, 7.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.03, 9.01
same event type: other_material
similar materiality
This filing
the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant ("Amended 2023 Prefunded Warrant"), (ii) an Amended and Restated June 2023 Tranche A Warrant ("Amended 2023 Tranche A Warrant") and (iii) an Amended and Restated June 2025 Prefunded Warrant ("Amended 2025 Prefunded Warrant"), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers
Comparable filing
Argent Trust Company, the trustee of the Trust, entered into Amendment No. 2 to the Amended and Restated Trust Indenture of Permian Basin Royalty Trust dated May 8, 2026 (the “Amendment”) implementing the modifications approved by the Court.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.